Patents by Inventor Behram Sethna
Behram Sethna has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250084119Abstract: The present disclosure provides pyrrolopyrimidine nucleoside analogs of the Formula I, Formula IA, Formula IB, or Formula II and phospholipid conjugates and pharmaceutical compositions thereof wherein Rc and A are defined herein. Also presented are methods of treating and/or preventing viral infection and/or viral infection-associated disease or disorder with one or more compounds of Formula I, Formula IA, Formula IB, or Formula II.Type: ApplicationFiled: March 19, 2024Publication date: March 13, 2025Inventors: John Henry BOUGHER, III, Ramamurty V S CHANGALVALA, Aaron Leigh DOWNEY, John C. DRACH, Ernest Randall LANIER, JR., Andrew Louis MCIVER, Bradley David ROBERTSON, Dean Wallace SELLESETH, Phiroze Behram SETHNA, Leroy TOWNSEND, Roy W. WARE
-
Publication number: 20240238297Abstract: This disclosure relates, at least in part, to a method of treatment. In one embodiment, the method of treatment comprises administering to a subject in need of such treatment at least a first therapeutic agent including ONC-206, 7-benzyl-4-(2,4-difluorobenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one, for the treatment of one or more CNS neoplasms.Type: ApplicationFiled: May 13, 2022Publication date: July 18, 2024Inventors: Joshua Edward Allen, Jill Christine CHAPPELL, Andrew Kang-Kang LEE, Odin Johann NADERER, Varun Vijay PRABHU, Phiroze Behram SETHNA
-
Publication number: 20240207299Abstract: The present disclosure provides methods of treating or preventing a SARS-CoV-2 infection or a SARS-CoV-2-infection associated disease or disorder (e.g. COVID-19) comprising administering to a subject in need thereof an effective amount of a pyrrolopyrimidine nucleoside analog of the Formula I, Formula IA, Formula IB or Formula II and pharmaceutical compositions thereof wherein Rc and A are defined herein.Type: ApplicationFiled: March 29, 2022Publication date: June 27, 2024Applicant: Chimerix, Inc.Inventors: Heidi Muth COLTON, Mohammed Anowrul KABIR, Ernest Randall LANIER, Jr., Phiroze Behram SETHNA, Roy W. WARE
-
Patent number: 11981700Abstract: The present disclosure provides pyrrolopyrimidine nucleoside analogs of the Formula I, Formula IA, Formula IB, or Formula II and phospholipid conjugates and pharmaceutical compositions thereof wherein Rc and A are defined herein. Also presented are methods of treating and/or preventing viral infection and/or viral infection-associated disease or disorder with one or more compounds of Formula I, Formula IA, Formula IB, or Formula II.Type: GrantFiled: January 27, 2021Date of Patent: May 14, 2024Assignees: Chimerix, Inc., The Regents of the University of MichiganInventors: John Henry Bougher, III, Ramamurty V S Changalvala, Aaron Leigh Downey, John C. Drach, Ernest Randall Lanier, Jr., Andrew Louis McIver, Bradley David Robertson, Dean Wallace Selleseth, Phiroze Behram Sethna, Leroy Townsend, Roy W. Ware
-
Publication number: 20220002335Abstract: The present disclosure provides pyrrolopyrimidine nucleoside analogs of the Formula I, Formula IA, Formula IB, or Formula II and phospholipid conjugates and pharmaceutical compositions thereof wherein Rc and A are defined herein. Also presented are methods of treating and/or preventing viral infection and/or viral infection-associated disease or disorder with one or more compounds of Formula I, Formula IA, Formula IB, or Formula II.Type: ApplicationFiled: January 27, 2021Publication date: January 6, 2022Inventors: John Henry BOUGHER, III, Ramamurty V S CHANGALVALA, Aaron Leigh DOWNEY, John C. DRACH, Ernest Randall LANIER, JR., Andrew Louis MCIVER, Bradley David ROBERTSON, Dean Wallace SELLESETH, Phiroze Behram SETHNA, Leroy TOWNSEND, Roy W. WARE
-
Patent number: 10941175Abstract: The present disclosure provides pyrrolopyrimidine nucleoside analogs of the Formula I, Formula IA, Formula IB, or Formula II and phospholipid conjugates and pharmaceutical compositions thereof wherein Rc and A are defined herein. Also presented are methods of treating and/or preventing viral infection and/or viral infection-associated disease or disorder with one or more compounds of Formula I, Formula IA, Formula IB, or Formula II.Type: GrantFiled: August 6, 2019Date of Patent: March 9, 2021Assignees: Chimerix, Inc., The Regents of the University of MichiganInventors: John Henry Bougher, III, Ramamurty V S Changalvala, Aaron Leigh Downey, John C. Drach, Ernest Randall Lanier, Jr., Andrew Louis McIver, Bradley David Robertson, Dean Wallace Selleseth, Phiroze Behram Sethna, Leroy Townsend, Roy W. Ware
-
Publication number: 20200199167Abstract: The present disclosure provides pyrrolopyrimidine nucleoside analogs of the Formula I, Formula IA, Formula IB, or Formula II and phospholipid conjugates and pharmaceutical compositions thereof wherein Rc and A are defined herein. Also presented are methods of treating and/or preventing viral infection and/or viral infection-associated disease or disorder with one or more compounds of Formula I, Formula IA, Formula IB, or Formula II.Type: ApplicationFiled: August 6, 2019Publication date: June 25, 2020Inventors: John Henry BOUGHER, III, Ramamurty V S CHANGALVALA, Aaron Leigh DOWNEY, John C. DRACH, Ernest Randall LANIER, Jr., Andrew Louis MCIVER, Bradley David ROBERTSON, Dean Wallace SELLESETH, Phiroze Behram SETHNA, Leroy TOWNSEND, Roy W. WARE
-
Patent number: 10407457Abstract: The present disclosure provides pyrrolopyrimidine nucleoside analogs of the Formula I, Formula IA, Formula IB, or Formula II and phospholipid conjugates and pharmaceutical compositions thereof wherein Rc and A are defined herein. Also presented are methods of treating and/or preventing viral infection and/or viral infection-associated disease or disorder with one or more compounds of Formula I, Formula IA, Formula IB, or Formula II.Type: GrantFiled: May 18, 2017Date of Patent: September 10, 2019Assignees: Chimerix, Inc., The Regents of the University of MichiganInventors: John Henry Bougher, III, Ramamurty V S Changalvala, John C. Drach, Ernest Randall Lanier, Jr., Andrew Louis McIver, Bradley David Robertson, Dean Wallace Selleseth, Phiroze Behram Sethna, Leroy Townsend, Roy W. Ware
-
Publication number: 20170253628Abstract: The present disclosure provides pyrrolopyrimidine nucleoside analogs of the Formula I, Formula IA, Formula IB, or Formula II and phospholipid conjugates and pharmaceutical compositions thereof wherein Rc and A are defined herein. Also presented are methods of treating and/or preventing viral infection and/or viral infection-associated disease or disorder with one or more compounds of Formula I, Formula IA, Formula IB, or Formula II.Type: ApplicationFiled: May 18, 2017Publication date: September 7, 2017Inventors: John Henry Bougher, III, Ramamurty V S Changalvala, Aaron Leigh Downey, John C. Drach, Ernest Randall Lanier, JR., Andrew Louis McIver, Bradley David Robertson, Dean Wallace Selleseth, Phiroze Behram Sethna, Leroy Townsend, Roy W. Ware
-
Patent number: 9708359Abstract: The present disclosure provides pyrrolopyrimidine nucleoside analogs of the Formula I, Formula IA, Formula IB, or Formula II and phospholipid conjugates and pharmaceutical compositions thereof wherein Rc and A are defined herein. Also presented are methods of treating and/or preventing viral infection and/or viral infection-associated disease or disorder with one or more compounds of Formula I, Formula IA, Formula IB, or Formula II.Type: GrantFiled: August 8, 2016Date of Patent: July 18, 2017Assignees: Chimerix, Inc., The Regents of the University of MichiganInventors: John Henry Bougher, III, Ramamurty V S Changalvala, Aaron Leigh Downey, John C. Drach, Ernest Randall Lanier, Jr., Andrew Louis McIver, Bradley David Robertson, Dean Wallace Selleseth, Phiroze Behram Sethna, Leroy Townsend, Roy W. Ware
-
Patent number: 9701706Abstract: The present disclosure provides pyrrolopyrimidine nucleoside analogs of the Formula I, Formula IA, Formula IB, or Formula II and phospholipid conjugates and pharmaceutical compositions thereof wherein Rc and A are defined herein. Also presented are methods of treating and/or preventing viral infection and/or viral infection-associated disease or disorder with one or more compounds of Formula I, Formula IA, Formula IB, or Formula II.Type: GrantFiled: November 22, 2016Date of Patent: July 11, 2017Assignees: Chimerix, Inc., The Regents of the University of MichiganInventors: John Henry Bougher, III, Ramamurty V S Changalvala, John C. Drach, Ernest Randall Lanier, Jr., Andrew Louis McIver, Bradley David Robertson, Dean Wallace Selleseth, Phiroze Behram Sethna, Leroy Townsend, Roy W. Ware
-
Patent number: 9082042Abstract: A system for classifying moving objects during video-based surveillance comprising: capturing a silhouette image of a moving object, resizing the captured image, computing an average height to width ratio and a center of gravity for the object in the resized image, dividing the resized image, comparing the average height to average width of the object and further comparing the variance of center of gravity with a predetermined threshold value to classify the object in the captured silhouette into predetermined classes.Type: GrantFiled: July 29, 2011Date of Patent: July 14, 2015Assignees: TATA CONSULTANCY SERVICES, ANNA UNIVERSITYInventors: Behram Sethna, Mala John, Prasath Palaniappan, Sumithra Ganapathi
-
Publication number: 20120026328Abstract: A system for classifying moving objects during video-based surveillance comprising: capturing a silhouette image of a moving object, resizing the captured image, computing an average height to width ratio and a center of gravity for the object in the resized image, dividing the resized image, comparing the average height to average width of the object and further comparing the variance of center of gravity with a predetermined threshold value to classify the object in the captured silhouette into predetermined classes.Type: ApplicationFiled: July 29, 2011Publication date: February 2, 2012Applicants: TATA CONSULTANCY SERVICES LIMITED, ANNA UNIVERSITYInventors: Behram Sethna, Mala John, Prasath Palaniappan, Sumithra Ganapathi